AbCellera Biologics Inc. ABCL Payments for (Proceeds from) Loans Receivable
Payments for (Proceeds from) Loans Receivable at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsForProceedsFromLoansReceivable.
The official record: AbCellera Biologics Inc.’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s payments for (proceeds from) loans receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s payments for (proceeds from) loans receivable?
- AbCellera Biologics Inc. (ABCL) reported payments for (proceeds from) loans receivable of -$8.32M in Q4 2025.
- What does payments for (proceeds from) loans receivable mean?
- This metric represents the net cash flow resulting from the issuance of loans to third parties or the collection of principal on existing loan receivables. It reflects the company's activity in providing financing or managing credit-based assets as part of its broader capital management strategy.